ADVANCED GASTROESOPHAGEAL JUNCTION CANCER
Clinical trials for ADVANCED GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED GASTROESOPHAGEAL JUNCTION CANCER trials appear
Sign up with your email to follow new studies for ADVANCED GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fight advanced stomach cancer when standard treatments fail
Disease control Recruiting nowThis phase 2 trial tests an experimental drug called SAR445877 in adults with advanced gastric or gastroesophageal junction cancer that has worsened after at least one prior treatment. The study includes about 30 participants and looks at whether the drug can shrink tumors. It is…
Matched conditions: ADVANCED GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New Immune-Targeting drug combo takes on advanced cancers
Disease control Recruiting nowThis study tests a new drug called LM-108, which clears certain immune cells from tumors, combined with standard chemotherapy and another immunotherapy. The goal is to see if this mix is safe and can slow or shrink advanced solid tumors. About 194 adults with advanced cancers wil…
Matched conditions: ADVANCED GASTROESOPHAGEAL JUNCTION CANCER
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC